Uploaded September 2026 | Updated November 2026, 5 days ago
Early-stage startups face something called the “liability of newness” so they have to signal credibility to investors.
Dr. Eike Gerhardt breaks down how Nephrogen founder Demetri Maxim used his Startup Battlefield pitch to overcome it.
Watch the full episode of Build Mode for more startup pitching advice. spr.ly/6052BGBkmk
Early-stage startups face something called the “liability of newness” so they have to signal credibility to investors.
Dr. Eike Gerhardt breaks down how Nephrogen founder Demetri Maxim used his Startup Battlefield pitch to overcome it.
Watch the full episode of Build Mode for more startup pitching advice. spr.ly/6052BGBkmk










